Close



Apr 16, 2024 07:01AM
Apr 16, 2024 07:00AM
Apr 4, 2024 08:08AM
Feb 22, 2024 07:30AM
Dec 5, 2023 08:00AM
Nov 2, 2023 07:30AM
Sep 11, 2023 08:00AM Intra-Cellular Therapies Announces Presentations at Psych Congress 2023 Including Positive Results from Study 403 in Mixed Features
Aug 3, 2023 07:30AM
May 31, 2023 08:00AM
May 4, 2023 07:30AM
Mar 28, 2023 07:03AM
Mar 28, 2023 07:00AM
Mar 1, 2023 07:30AM
Dec 8, 2022 08:00AM Intra-Cellular Therapies Highlights New CAPLYTA Bipolar Depression Data Presentations at the American College of Neuropsychopharmacology 61st Annual Meeting
Nov 3, 2022 07:30AM
Aug 9, 2022 07:30AM
Jun 13, 2022 08:00AM
May 10, 2022 07:30AM
Apr 25, 2022 07:03AM
Apr 25, 2022 07:00AM
Mar 1, 2022 07:30AM Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
Dec 20, 2021 11:39AM
Dec 20, 2021 10:17AM
Dec 20, 2021 08:58AM
Dec 20, 2021 08:28AM
Dec 20, 2021 06:47AM
Dec 20, 2021 06:47AM
Dec 6, 2021 06:41AM Needham & Company Previews Intra-Cellular Therapies (ITCI) Dec. 17th PDUFA for Caplyta
Nov 9, 2021 07:30AM
Oct 21, 2021 08:42AM
Oct 18, 2021 05:18AM
Sep 27, 2021 07:30AM
Sep 27, 2021 07:30AM
Sep 20, 2021 07:30AM
Aug 9, 2021 07:30AM Intra-Cellular Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Jun 7, 2021 08:05AM
Jun 7, 2021 08:00AM
May 10, 2021 07:35AM
May 10, 2021 07:30AM
May 3, 2021 07:31AM
May 3, 2021 07:30AM
Apr 22, 2021 07:30AM Intra-Cellular Therapies Announces Investor Webcast and Presentations on Lumateperone Programs at the Upcoming American Psychiatric Association (APA) Annual Meeting
Apr 20, 2021 07:00AM
Apr 19, 2021 09:05AM
Apr 12, 2021 07:30AM
Feb 25, 2021 07:30AM
Feb 24, 2021 07:30AM
Feb 22, 2021 08:09AM
Feb 22, 2021 08:00AM Intra-Cellular Therapies Applies for FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression
Jan 21, 2021 08:09AM

251,395 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All